Use: Labeled indications
- Uses - cure most jock itch (tinea cruris) and ringworm (tinea corporis) - relieves itching, burning, cracking andf scaling which accompany this condition
Full indications and usage US FDA label
Uses - cure most jock itch (tinea cruris) and ringworm (tinea corporis) - relieves itching, burning, cracking andf scaling which accompany this condition
Dosing: Adult
Dosage and administration (US label) US FDA label
Directions - adults and children 12 years and over: use the tip of the cap to break the seal and open the tube wash the affected skin with soap and water and dry completely before applying for athlete's foot wear well-fitting, ventilated shoes. Change shoes and socks at least once daily. between the toes only: apply twice a day (morning and night) for 1 week or as directed by a doctor on the bottom or sides of the foot: apply twice a day (morning and night) for 2 weeks or as directed by a doctor for jock itch and ringworm: apply once a day (morning or night) for 1 week or as directed by a doctor wash hands after each use - children under 12 years: ask a doctor
Dosing: Altered kidney function
No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.
Kidney-specific guidance from renalcarematters.com: in preparation.
Dosage forms
Philippines
- Topical cream: 10 mg/g
- Cream: 10 mg, 10 mg/g
- Film-coated tablet: 250 mg
- Tablet: 250 mg
- Topical spray solution: 10 mg/mL
- W/w) cream: 10 mg/g (1 %
Registered products in the Philippines
24 products registered with the Food and Drug Administration (FDA) Philippines list Terbinafine as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.
All registered products24
| Package insert | |||||||
|---|---|---|---|---|---|---|---|
AkrifineTerbinafine (as hydrochloride) | 10 mg/g (1%w/w) CreamAluminium Tube x 10 g (Box of 1's) | OTC | AKRITI PHARMACEUTICALS PVT. LTD.India | Aglobal Care, Inc. | DRP-14271 | Aug 7, 2028 | |
AntergalTerbinafine (as hydrochloride) | 10 mg/g (1% w/w) Topical CreamAluminum Tube x 30 g (Box of 1's) | OTC | Santa Farma İlaç San. A.Ş.Turkey | Orange Biotec Inc. | DRP-16579 | May 9, 2030 | |
DermifeneTerbinafine hydrochloride | 10 mg/g CreamLaminated Aluminum Tube x 10 g & 15 g | Rx | Interphil Laboratories, Inc.Philippines | — | DRP-3650 | Aug 11, 2028 | |
FinazylTerbinafine Hydrochloride | 10 mg/mL (1% w/v) Topical Spray SolutionHigh Density White Polyethylene (Polyolefin) Plastic Bottle with Pump Spray System in 15 mL (net content) Box of 10's | Rx | Jewim Pharmaceutical (Shandong) Co., Ltd.China | Global Pharmatrade | DR-XY43652 | Aug 20, 2029 | |
LamisilTerbinafine (as hydrochloride) | 250 mg TabletAlu/PVC blister pack x 14's per box | Rx | Novartis Pharma Produktions GmbHGermany | Importer: Novartis Healthcare Philippines, Inc. | DR-XY15999 | Oct 30, 2027 | |
Lamisil AFTerbinafine (as hydrochloride) | 10 mg/g (1%) CreamAluminum Tube of 3 g (Box of 1's); Aluminum Tube of 5 g (Box of 1's); Aluminum Tube of 10 g (Box of 1's) | OTC | GlaxoSmithKline Consumer Health Care Pakistan LimitedPakistan | Importer: GlaxoSmithKline Consumer Healthcare Philippines, Inc. | DR-XY16056 | Jun 23, 2028 | |
LuktechTerbinafine Hydrochloride | 10 mg/g (1% w/w) Topical CreamAluminum Tube with HDPE Screw Cap x 3 g, 5 g, 10 g, 15 g and 20 g (Box of 1's) | OTC | Azarias Pharmaceutical Laboratories Inc.,Philippines | — | DRP-18300 | Jun 8, 2032 | |
NoneTerbinafine (as hydrochloride) | 10 mg/ g (1% w/w) Topical Cream3 g, 5 g and 10 g Collapsible aluminum tube (Box of 1 tube) | OTC | Amherst Laboratories, Inc.Philippines | Trader: Ritemed Phils., Inc. | DR-XY46070 | Oct 4, 2027 | |
NoneTerbinafine hydrochloride | 10 mg/g CreamLaminated Aluminum Tube x 10 g Box of 1's | Rx | Interphil Laboratories, Inc.Philippines | Neodrug Inc. | DRP-3650-02 | Aug 11, 2028 | |
NoneTerbinafine hydrochloride | 10 mg/g CreamLaminated Aluminum Tube x 15 g (Box of 1's) | Rx | Interphil Laboratories, Inc.Philippines | Ritemed Phils., Inc. | DRP-3650-03 | Aug 11, 2028 | |
NovafineTerbinafine (as Hydrochloride) | 10 mg/g (1.0% w/w) Topical CreamAluminum Collapsible Tube x 5 g, 10 g and 30 g (Box of 1's) | OTC | S Kant Healthcare Ltd.India | Medinova Pharmaceutical Inc. | DRP-16878 | Aug 8, 2030 | |
TebfinTerbinafine (as hydrochloride) | 10mg/g (1% w/w) Topical CreamCollapsible Aluminum Tube with White PET Screw Cap x 10 g (Box of 1’s) | OTC | Front Pharmaceutical PLCChina | Hexagon Pharmaceuticals | DR-XY46541 | Mar 22, 2029 | |
TenafineTerbinafine (As Hydrochloride) | 10 mg/g (1% w/w) Topical CreamAluminum Tube With Cap X 15 g (Box of 1's) | OTC | Dae Hwa Pharmaceutical Co., Ltd.Republic of Korea | Bellus Life Solutions, Inc. | DRP-9007 | Aug 3, 2031 | |
Ter-BTerbinafine Hydrochloride | 10 mg/g (1% w/w) Topical CreamPrinted Laminated Tube x 10 g (Box of 1's) | OTC | KLM Laboratories Pvt. Ltd.India | Brady Pharma Inc.Importer: AMB HK Enterprises Inc. | DRP-12044-02 | Jun 2, 2027 | |
TerbifinTerbinafine (As Hydrochloride) | 10 mg (1 % w/w) CreamLaminated Tube x 5 g & 10 g in a Box | Rx | Aristopharma Ltd.Bangladesh | Sahar International Trading, Inc. | DR-XY41550 | Oct 13, 2027 | |
TerbifinTerbinafine (as Hydrochloride) | 250 mg TabletAlu/Alu Blister Pack x 6's (Box of 12's) | Rx | Aristopharma Ltd.Bangladesh | Sahar International Trading, Inc. | DR-XY42526 | Sep 5, 2028 | |
TerbifredTerbinafine Hydrochloride | 10 mg/g (1% w/w) Topical CreamPrinted Laminated Tube x 10 g (Box of l's); Printed Laminated Tube x 15 g (Box of l's) | OTC | Fredun Pharmaceuticals LimitedIndia | AMB HK Enterprises Inc. | DRP-12641 | Sep 19, 2027 | |
TerbifredTerbinafine Hydrochloride | 10mg/g (1% w/w) Topical CreamLaminated Tube x 10 g and 15 g (Box of 1's) | OTC | Fredun Pharmaceuticals LimitedIndia | AMB HK Enterprises Inc. | DRP-12956 | Nov 9, 2027 | |
TerbinoxTerbinafine Hydrochloride | 10 mg/ g (1% w/w) Topical CreamPrinted Laminated Tube x 5 g and 10 g (Box of 1's) | OTC | KLM Laboratories Pvt. Ltd.India | FSPC Pharmaceuticals Inc.Importer: AMB HK Enterprises Inc. | DRP-12044 | Jun 2, 2032 | |
TerbiphilTerbinafine Hydrochloride | 10mg/g (1% w/w) Topical CreamPrinted Laminated Tube x 10g (Box of 1's) | OTC | KLM Laboratories Pvt. Ltd.India | Philrx Pharma Inc.Importer: AMB HK Enterprises Inc. | DRP-12044-01 | Jun 2, 2027 | |
TerbividTerbinafine Hydrochloride | 10 mg/g (1% w/w) CreamCollapsible Aluminum Tube Sealed with White HDPE Screw Cap x 15 g (Box of 1's) | Rx | Hovid BerhadMalaysia | Hovid, Inc. | DRP-10284 | Sep 3, 2031 | |
TerbizedTerbinafine Hydrochloride | 10 mg/g (1% w/w) CreamAluminum Collapsible Tube x 10 g (Box of 1's) | Rx | Agio Pharmaceuticals Ltd.India | Ambica International Corporation | DRP-4569 | Jul 26, 2028 | |
TerboxorTerbinafine (as hydrochloride) | 250 mg Film-Coated TabletAlu/Clear PVC Blister Pack x 10's (Box of 30's) | Rx | BDA Healthcare Pvt. Ltd.India | Orange Biotec, Inc. | DRP-14593 | Oct 20, 2028 | |
TerboxorTerbinafine (As Hydrochloride) | 250mg Film-Coated TabletAlu-PVC Blister pack x 10's (Box of 30's) | Rx | BDA Healthcare Pvt. Ltd.India | Orange Biotec Inc.Trader: N/A | DRP-145993 | Oct 20, 2028 |
Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.
Warnings/Precautions
Warnings and precautions (US label) US FDA label
Warnings For external use only Do not use - on nails or scalp - in or near the mouth or eyes - for vaginal yeast infections When using this product do not get into eyes. If eye contact occurs, rinse thoroughly with water Stop use and ask a doctor if too much irritation occurs or gets worse Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
Formulary and pricing (Philippines)
Formulary and coverage
| Philippine National Formulary | Listed as Terbinafine |
| PNF listing | Oral: 250 mg tablet |
| PNF listing | Cream: 1%, 3 g, 5 g, 10 g and 15 g tube (as hydrochloride) |
| PhilHealth GAMOT | No |
Sources:
- PNF Essential Medicines List, 8th ed. (as of November 2, 2022), DOH; https://www.philhealth.gov.ph/partners/providers/pdf/PNF-EML_11022022.pdf, as of November 2, 2022
Check availability
Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.
References
- U.S. Food and Drug Administration. Lamisil AT Cream · Voyant Beauty Inc. [US FDA-approved label, version 6, November 18, 2025]. Via DailyMed/openFDA. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9dea4789-bf1c-1577-e053-2a95a90a5381
- Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph
- PNF Essential Medicines List, 8th ed. (as of November 2, 2022), DOH; https://www.philhealth.gov.ph/partners/providers/pdf/PNF-EML_11022022.pdf
This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.
Last updated: .